Identification of a small-molecule inhibitor of the interaction between Survivin and Smac/DIABLO

Biochemical and Biophysical Research Communications

Volumn 393, Issue 2, 2010, Pages 253-258

  Oikawa, Tsuyoshi ^a   Unno, Yuka ^a   Matsuno, Kenji ^a   Sawada, Jun ichi ^a   Ogo, Naohisa ^b   Tanaka, Kiyoshi ^a   Asai, Akira ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SHIZUOKA INSTITUTE OF ENVIRONMENT AND HYGIENE   (Japan)

Author keywords

5 Deazaflavin; Apoptosis; High throughput screening; Smac DIABLO; Survivin

Indexed keywords

DOXORUBICIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL DIVISION; CELL SURVIVAL; DNA DAMAGE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR LIBRARY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANTIBIOTICS, ANTINEOPLASTIC; CELL PROLIFERATION; DOXORUBICIN; DRUG SYNERGISM; FLAVINS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL PROTEINS;

EID: 77649188793     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.113     Document Type: Article

References (23)

1. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
2. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by Survivin. Nature 396 (1998) 580-584
3. Giodini A., Kallio M.J., Wall N.R., Gorbsky G.J., Tognin S., Marchisio P.C., Symons M., and Altieri D.C. Regulation of microtubule stability and mitotic progression by Survivin. Cancer Res. 62 (2002) 2462-2467
4. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., and Altieri D.C. Developmentally regulated expression of the novel cancer anti-apoptosis gene Survivin in human and mouse differentiation. Am. J. Pathol. 152 (1998) 43-49
5. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J., Maestre J., Martin C., Font A., Barnadas A., and Abad A. A novel anti-apoptosis gene: Re-expression of Survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17 (1999) 2100-2104
6. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., and Tanigawa N. Expression of Survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6 (2000) 127-134
7. Grossman D., Kim P.J., Blanc-Brude O.P., Brash D.E., Tognin S., Marchisio P.C., and Altieri D.C. Transgenic expression of Survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108 (2001) 991-999
8. Dean E.J., Ranson M., Blackhall F., Holt S.V., and Dive C. Novel therapeutic targets in lung cancer: inhibitor of apoptosis proteins from laboratory to clinic. Cancer Treat. Rev. 33 (2007) 203-212
9. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
10. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., and Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
11. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., and Oh B.H. An anti-apoptotic protein human Survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40 (2001) 1117-1123
12. Arnt C.R., Chiorean M.V., Heldebrant M.P., Gores G.J., and Kaufmann S.H. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J. Biol. Chem. 277 (2002) 44236-44243
13. Banks D.P., Plescia J., Altieri D.C., Chen J., Rosenberg S.H., Zhang H., and Ng S.C. Survivin does not inhibit caspase-3 activity. Blood 96 (2000) 4002-4003
14. Li C., Wu Z., Liu M., Pazgier M., and Lu W. Chemically synthesized human Survivin does not inhibit caspase-3. Protein Sci. 17 (2008) 1624-1629
15. Song Z., Yao X., and Wu M. Direct interaction between Survivin and Smac/DIABLO is essential for the anti-apoptotic activity of Survivin during taxol-induced apoptosis. J. Biol. Chem. 25 (2003) 23130-23140
16. Vader G., Kauw J.J., Medema R.H., and Lens S.M. Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep. 7 (2006) 85-92
17. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., and Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 131 (2007) 271-285
18. Li F., Ackermann E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., Villa A., Marchisio P.C., and Altieri D.C. Pleiotropic cell-division defects and apoptosis induced by interference with Survivin function. Nat. Cell Biol. 1 (1999) 461-466
19. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer. 8 (2008) 61-70
20. Ryan B.M., O'Donovan N., and Duffy M.J. Survivin: a new target for anti-cancer therapy. Cancer Treat. Rev. 35 (2009) 553-562
21. Bolton M.A., Lan W., Powers S.E., McCleland M.L., Kuang J., and Stukenberg P.T. Aurora B kinase exists in a complex with Survivin and INCENP and its kinase activity is stimulated by Survivin binding and phosphorylation. Mol. Biol. Cell.13 (2002) 3064-3077
22. Song Z., Liu S., He H., Hoti N., Wang Y., Feng S., and Wu M. A single amino acid change (Asp53 → Ala53) converts Survivin from anti-apoptotic to pro-apoptotic. Mol. Biol. Cell 15 (2004) 1287-1296
23. Ogura A., Watanabe Y., Iizuka D., Yasui H., Amitani M., Kobayashi S., Kuwabara M., and Inanami O. Radiation-induced apoptosis of tumor cells is facilitated by inhibition of the interaction between Survivin and Smac/DIABLO. Cancer Lett. 259 (2008) 71-81